Home

Dulap Mov pustietate gene asxl1 lungime angrena Doctor

Mutations in ASXL1 are associated with poor prognosis across the spectrum  of malignant myeloid diseases | Journal of Hematology & Oncology | Full Text
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases | Journal of Hematology & Oncology | Full Text

ASXL1 mutations are associated with distinct epigenomic alterations that  lead to sensitivity to venetoclax and azacytidine | Blood Cancer Journal
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine | Blood Cancer Journal

Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function  mutated leukemia | Nature Cancer
Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia | Nature Cancer

Epigenetic regulation by ASXL1 in myeloid malignancies | International  Journal of Hematology
Epigenetic regulation by ASXL1 in myeloid malignancies | International Journal of Hematology

ASXL1/2 mutations and myeloid malignancies | Journal of Hematology &  Oncology | Full Text
ASXL1/2 mutations and myeloid malignancies | Journal of Hematology & Oncology | Full Text

Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding |  bioRxiv
Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding | bioRxiv

Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms  | International Journal of Hematology
Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms | International Journal of Hematology

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia  cells and increases survival in mouse xenografts. - Abstract - Europe PMC
ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts. - Abstract - Europe PMC

ASXL1 (additional sex combs like 1 (Drosophila))
ASXL1 (additional sex combs like 1 (Drosophila))

ASXL1/2 mutations and myeloid malignancies | Journal of Hematology &  Oncology | Full Text
ASXL1/2 mutations and myeloid malignancies | Journal of Hematology & Oncology | Full Text

Generation of the Asxl1 G643WfsX12 knock-in mice. a Schematic... | Download  Scientific Diagram
Generation of the Asxl1 G643WfsX12 knock-in mice. a Schematic... | Download Scientific Diagram

Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish  | Leukemia
Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish | Leukemia

ASXL1 promotes adrenocortical carcinoma and is associated with  chemoresistance to EDP regimen - Figure f1 | Aging
ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen - Figure f1 | Aging

CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal  aberrations constitute molecular events in chronic myelogenous leukemia -  ScienceDirect
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia - ScienceDirect

Role of ASXL1 in hematopoiesis and myeloid diseases - ScienceDirect
Role of ASXL1 in hematopoiesis and myeloid diseases - ScienceDirect

Hypothetical model for the role of ASXL1 in cell cycle progression... |  Download Scientific Diagram
Hypothetical model for the role of ASXL1 in cell cycle progression... | Download Scientific Diagram

ASXL1 | JCGA
ASXL1 | JCGA

Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish  | Leukemia
Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish | Leukemia

Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single  Human Cells | PLOS ONE
Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells | PLOS ONE

Epigenetics and mutations in chronic myeloproliferative neoplasms |  Haematologica
Epigenetics and mutations in chronic myeloproliferative neoplasms | Haematologica

Figure 1 from Role of ASXL1 and TP53 mutations in the molecular  classification and prognosis of acute myeloid leukemias with  myelodysplasia-related changes | Semantic Scholar
Figure 1 from Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes | Semantic Scholar

JCI - Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated  myeloid malignancies in preclinical models
JCI - Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models

JCI Insight - Multiomics of Bohring-Opitz syndrome truncating ASXL1  mutations identify canonical and noncanonical Wnt signaling dysregulation
JCI Insight - Multiomics of Bohring-Opitz syndrome truncating ASXL1 mutations identify canonical and noncanonical Wnt signaling dysregulation

ASXL1/2 mutations and myeloid malignancies | Journal of Hematology &  Oncology | Full Text
ASXL1/2 mutations and myeloid malignancies | Journal of Hematology & Oncology | Full Text

Schematic representation of the ASXL1 mutation in exon 12. The various... |  Download Scientific Diagram
Schematic representation of the ASXL1 mutation in exon 12. The various... | Download Scientific Diagram

Acquired ASXL1 mutations are common in patients with inherited GATA2  mutations and correlate with myeloid transformation | Haematologica
Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation | Haematologica

ASXL1 - Wikipedia
ASXL1 - Wikipedia